Home > > > Report Detail

Global Circulating Biomarker for Liquid Biopsy Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 06-Oct-2022
No. of pages: 100
Inquire Before Buying

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Circulating Biomarker for Liquid Biopsy companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Circulating Biomarker for Liquid Biopsy market. Further, it explains the major drivers and regional dynamics of the global Circulating Biomarker for Liquid Biopsy market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Abbott Laboratories

- Becton, Dickinson and Company

- GE Healthcare

- Epigenomics AG

- Agilent Technologies

- Biocept

- Affymetrix

- Fluxion Biosciences

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Circulating Biomarker for Liquid Biopsy Segment by Type

- Circulating Tumor Cells (CTCs)

- Circulating Tumor DNA (ctDNA)

- Cell-Free DNA (cfDNA)

- Extracellular Vesicles (EVs)

- Others

Circulating Biomarker for Liquid Biopsy Segment by Application

- Early Cancer Screening

- Therapy Selection

- Treatment Monitoring

- Recurrence Monitoring Orthopedics

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Circulating Biomarker for Liquid Biopsy market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Circulating Biomarker for Liquid Biopsy market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Circulating Biomarker for Liquid Biopsy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Circulating Biomarker for Liquid Biopsy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Circulating Biomarker for Liquid Biopsy revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Circulating Biomarker for Liquid Biopsy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Circulating Biomarker for Liquid Biopsy revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Abbott Laboratories, Becton, Dickinson and Company, GE Healthcare, Epigenomics AG, Agilent Technologies, Biocept, Affymetrix and Fluxion Biosciences, etc.

Global Circulating Biomarker for Liquid Biopsy Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Circulating Biomarker for Liquid Biopsy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Circulating Tumor Cells (CTCs)
1.2.3 Circulating Tumor DNA (ctDNA)
1.2.4 Cell-Free DNA (cfDNA)
1.2.5 Extracellular Vesicles (EVs)
1.2.6 Others
1.3 Market by Application
1.3.1 Global Circulating Biomarker for Liquid Biopsy Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Early Cancer Screening
1.3.3 Therapy Selection
1.3.4 Treatment Monitoring
1.3.5 Recurrence Monitoring Orthopedics
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Circulating Biomarker for Liquid Biopsy Market Size (2017-2028)
2.2 Circulating Biomarker for Liquid Biopsy Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Circulating Biomarker for Liquid Biopsy Market Size by Region (2017-2022)
2.4 Global Circulating Biomarker for Liquid Biopsy Market Size Forecast by Region (2023-2028)
2.5 Global Top Circulating Biomarker for Liquid Biopsy Countries Ranking by Market Size
3 Circulating Biomarker for Liquid Biopsy Competitive by Company
3.1 Global Circulating Biomarker for Liquid Biopsy Revenue by Players
3.1.1 Global Circulating Biomarker for Liquid Biopsy Revenue by Players (2017-2022)
3.1.2 Global Circulating Biomarker for Liquid Biopsy Market Share by Players (2017-2022)
3.2 Global Circulating Biomarker for Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Circulating Biomarker for Liquid Biopsy Revenue
3.4 Global Circulating Biomarker for Liquid Biopsy Market Concentration Ratio
3.4.1 Global Circulating Biomarker for Liquid Biopsy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circulating Biomarker for Liquid Biopsy Revenue in 2021
3.5 Global Circulating Biomarker for Liquid Biopsy Key Players Head office and Area Served
3.6 Key Players Circulating Biomarker for Liquid Biopsy Product Solution and Service
3.7 Date of Enter into Circulating Biomarker for Liquid Biopsy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Circulating Biomarker for Liquid Biopsy Breakdown Data by Type
4.1 Global Circulating Biomarker for Liquid Biopsy Historic Revenue by Type (2017-2022)
4.2 Global Circulating Biomarker for Liquid Biopsy Forecasted Revenue by Type (2023-2028)
5 Global Circulating Biomarker for Liquid Biopsy Breakdown Data by Application
5.1 Global Circulating Biomarker for Liquid Biopsy Historic Market Size by Application (2017-2022)
5.2 Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Circulating Biomarker for Liquid Biopsy Revenue by Company (2020-2022)
6.2 North America Circulating Biomarker for Liquid Biopsy Revenue by Type (2017-2028)
6.3 North America Circulating Biomarker for Liquid Biopsy Revenue by Application (2017-2028)
6.4 North America Circulating Biomarker for Liquid Biopsy Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Circulating Biomarker for Liquid Biopsy Revenue by Company (2020-2022)
7.2 Europe Circulating Biomarker for Liquid Biopsy Revenue by Type (2017-2028)
7.3 Europe Circulating Biomarker for Liquid Biopsy Revenue by Application (2017-2028)
7.4 Europe Circulating Biomarker for Liquid Biopsy Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Circulating Biomarker for Liquid Biopsy Revenue by Company (2020-2022)
8.2 Asia Pacific Circulating Biomarker for Liquid Biopsy Revenue by Type (2017-2028)
8.3 Asia Pacific Circulating Biomarker for Liquid Biopsy Revenue by Application (2017-2028)
8.4 Asia Pacific Circulating Biomarker for Liquid Biopsy Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Circulating Biomarker for Liquid Biopsy Revenue by Company (2020-2022)
9.2 Latin America Circulating Biomarker for Liquid Biopsy Revenue by Type (2017-2028)
9.3 Latin America Circulating Biomarker for Liquid Biopsy Revenue by Application (2017-2028)
9.4 Latin America Circulating Biomarker for Liquid Biopsy Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Circulating Biomarker for Liquid Biopsy Revenue by Company (2020-2022)
10.2 Middle East and Africa Circulating Biomarker for Liquid Biopsy Revenue by Type (2017-2028)
10.3 Middle East and Africa Circulating Biomarker for Liquid Biopsy Revenue by Application (2017-2028)
10.4 Middle East and Africa Circulating Biomarker for Liquid Biopsy Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Circulating Biomarker for Liquid Biopsy Products and Services
11.1.4 Abbott Laboratories Circulating Biomarker for Liquid Biopsy Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
11.1.5 Abbott Laboratories Circulating Biomarker for Liquid Biopsy SWOT Analysis
11.1.6 Abbott Laboratories Recent Developments
11.2 Becton, Dickinson and Company
11.2.1 Becton, Dickinson and Company Company Details
11.2.2 Becton, Dickinson and Company Business Overview
11.2.3 Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Products and Services
11.2.4 Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
11.2.5 Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy SWOT Analysis
11.2.6 Becton, Dickinson and Company Recent Developments
11.3 GE Healthcare
11.3.1 GE Healthcare Company Details
11.3.2 GE Healthcare Business Overview
11.3.3 GE Healthcare Circulating Biomarker for Liquid Biopsy Products and Services
11.3.4 GE Healthcare Circulating Biomarker for Liquid Biopsy Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
11.3.5 GE Healthcare Circulating Biomarker for Liquid Biopsy SWOT Analysis
11.3.6 GE Healthcare Recent Developments
11.4 Epigenomics AG
11.4.1 Epigenomics AG Company Details
11.4.2 Epigenomics AG Business Overview
11.4.3 Epigenomics AG Circulating Biomarker for Liquid Biopsy Products and Services
11.4.4 Epigenomics AG Circulating Biomarker for Liquid Biopsy Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
11.4.5 Epigenomics AG Circulating Biomarker for Liquid Biopsy SWOT Analysis
11.4.6 Epigenomics AG Recent Developments
11.5 Agilent Technologies
11.5.1 Agilent Technologies Company Details
11.5.2 Agilent Technologies Business Overview
11.5.3 Agilent Technologies Circulating Biomarker for Liquid Biopsy Products and Services
11.5.4 Agilent Technologies Circulating Biomarker for Liquid Biopsy Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
11.5.5 Agilent Technologies Circulating Biomarker for Liquid Biopsy SWOT Analysis
11.5.6 Agilent Technologies Recent Developments
11.6 Biocept
11.6.1 Biocept Company Details
11.6.2 Biocept Business Overview
11.6.3 Biocept Circulating Biomarker for Liquid Biopsy Products and Services
11.6.4 Biocept Circulating Biomarker for Liquid Biopsy Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
11.6.5 Biocept Circulating Biomarker for Liquid Biopsy SWOT Analysis
11.6.6 Biocept Recent Developments
11.7 Affymetrix
11.7.1 Affymetrix Company Details
11.7.2 Affymetrix Business Overview
11.7.3 Affymetrix Circulating Biomarker for Liquid Biopsy Products and Services
11.7.4 Affymetrix Circulating Biomarker for Liquid Biopsy Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
11.7.5 Affymetrix Circulating Biomarker for Liquid Biopsy SWOT Analysis
11.7.6 Affymetrix Recent Developments
11.8 Fluxion Biosciences
11.8.1 Fluxion Biosciences Company Details
11.8.2 Fluxion Biosciences Business Overview
11.8.3 Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Products and Services
11.8.4 Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
11.8.5 Fluxion Biosciences Circulating Biomarker for Liquid Biopsy SWOT Analysis
11.8.6 Fluxion Biosciences Recent Developments
12 Circulating Biomarker for Liquid Biopsy Market Dynamics
12.1 Circulating Biomarker for Liquid Biopsy Market Trends
12.2 Circulating Biomarker for Liquid Biopsy Market Drivers
12.3 Circulating Biomarker for Liquid Biopsy Market Challenges
12.4 Circulating Biomarker for Liquid Biopsy Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Circulating Biomarker for Liquid Biopsy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Circulating Tumor Cells (CTCs)
Table 3. Key Players of Circulating Tumor DNA (ctDNA)
Table 4. Key Players of Cell-Free DNA (cfDNA)
Table 5. Key Players of Extracellular Vesicles (EVs)
Table 6. Key Players of Others
Table 7. Global Circulating Biomarker for Liquid Biopsy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Circulating Biomarker for Liquid Biopsy Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 9. Global Circulating Biomarker for Liquid Biopsy Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Region (2017-2022)
Table 11. Global Circulating Biomarker for Liquid Biopsy Revenue by Players (2017-2022) & (US$ Million)
Table 12. Global Circulating Biomarker for Liquid Biopsy Market Share by Players (2017-2022)
Table 13. Global Top Circulating Biomarker for Liquid Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Biomarker for Liquid Biopsy as of 2021)
Table 14. Ranking of Global Top Circulating Biomarker for Liquid Biopsy Companies by Revenue (US$ Million) in 2021
Table 15. Global 5 Largest Players Market Share by Circulating Biomarker for Liquid Biopsy Revenue (CR5 and HHI) & (2017-2022)
Table 16. Key Players Headquarters and Area Served
Table 17. Key Players Circulating Biomarker for Liquid Biopsy Product Solution and Service
Table 18. Date of Key Manufacturers Enter into Circulating Biomarker for Liquid Biopsy Market
Table 19. Mergers & Acquisitions, Expansion Plans
Table 20. Global Circulating Biomarker for Liquid Biopsy Market Size by Type (2017-2022) & (US$ Million)
Table 21. Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Type (2017-2022)
Table 22. Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 23. Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Type (2023-2028)
Table 24. Global Circulating Biomarker for Liquid Biopsy Market Size by Application (2017-2022) & (US$ Million)
Table 25. Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Application (2017-2022)
Table 26. Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 27. Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Application (2023-2028)
Table 28. North America Circulating Biomarker for Liquid Biopsy Revenue by Company (2020-2022) & (US$ Million)
Table 29. North America Circulating Biomarker for Liquid Biopsy Revenue by Type (2017-2022) & (US$ Million)
Table 30. North America Circulating Biomarker for Liquid Biopsy Revenue by Type (2023-2028) & (US$ Million)
Table 31. North America Circulating Biomarker for Liquid Biopsy Revenue by Application (2017-2022) & (US$ Million)
Table 32. North America Circulating Biomarker for Liquid Biopsy Revenue by Application (2023-2028) & (US$ Million)
Table 33. North America Circulating Biomarker for Liquid Biopsy Revenue by Country (2017-2022) & (US$ Million)
Table 34. North America Circulating Biomarker for Liquid Biopsy Revenue by Country (2023-2028) & (US$ Million)
Table 35. Europe Circulating Biomarker for Liquid Biopsy Revenue by Company (2020-2022) & (US$ Million)
Table 36. Europe Circulating Biomarker for Liquid Biopsy Revenue by Type (2017-2022) & (US$ Million)
Table 37. Europe Circulating Biomarker for Liquid Biopsy Revenue by Type (2023-2028) & (US$ Million)
Table 38. Europe Circulating Biomarker for Liquid Biopsy Revenue by Application (2017-2022) & (US$ Million)
Table 39. Europe Circulating Biomarker for Liquid Biopsy Revenue by Application (2023-2028) & (US$ Million)
Table 40. Europe Circulating Biomarker for Liquid Biopsy Revenue by Country (2017-2022) & (US$ Million)
Table 41. Europe Circulating Biomarker for Liquid Biopsy Revenue by Country (2023-2028) & (US$ Million)
Table 42. Asia Pacific Circulating Biomarker for Liquid Biopsy Revenue by Company (2020-2022) & (US$ Million)
Table 43. Asia Pacific Circulating Biomarker for Liquid Biopsy Revenue by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Circulating Biomarker for Liquid Biopsy Revenue by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Circulating Biomarker for Liquid Biopsy Revenue by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Circulating Biomarker for Liquid Biopsy Revenue by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Circulating Biomarker for Liquid Biopsy Revenue by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Circulating Biomarker for Liquid Biopsy Revenue by Region (2023-2028) & (US$ Million)
Table 49. Latin America Circulating Biomarker for Liquid Biopsy Revenue by Company (2020-2022) & (US$ Million)
Table 50. Latin America Circulating Biomarker for Liquid Biopsy Revenue by Type (2017-2022) & (US$ Million)
Table 51. Latin America Circulating Biomarker for Liquid Biopsy Revenue by Type (2023-2028) & (US$ Million)
Table 52. Latin America Circulating Biomarker for Liquid Biopsy Revenue by Application (2017-2022) & (US$ Million)
Table 53. Latin America Circulating Biomarker for Liquid Biopsy Revenue by Application (2023-2028) & (US$ Million)
Table 54. Latin America Circulating Biomarker for Liquid Biopsy Revenue by Country (2017-2022) & (US$ Million)
Table 55. Latin America Circulating Biomarker for Liquid Biopsy Revenue by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Circulating Biomarker for Liquid Biopsy Revenue by Company (2020-2022) & (US$ Million)
Table 57. Middle East and Africa Circulating Biomarker for Liquid Biopsy Revenue by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Circulating Biomarker for Liquid Biopsy Revenue by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Circulating Biomarker for Liquid Biopsy Revenue by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Circulating Biomarker for Liquid Biopsy Revenue by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Circulating Biomarker for Liquid Biopsy Revenue by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Circulating Biomarker for Liquid Biopsy Revenue by Country (2023-2028) & (US$ Million)
Table 63. Abbott Laboratories Company Details
Table 64. Abbott Laboratories Business Overview
Table 65. Abbott Laboratories Circulating Biomarker for Liquid Biopsy Product and Services
Table 66. Abbott Laboratories Circulating Biomarker for Liquid Biopsy Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 67. Abbott Laboratories Circulating Biomarker for Liquid Biopsy SWOT Analysis
Table 68. Abbott Laboratories Recent Developments
Table 69. Becton, Dickinson and Company Company Details
Table 70. Becton, Dickinson and Company Business Overview
Table 71. Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Product and Services
Table 72. Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 73. Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy SWOT Analysis
Table 74. Becton, Dickinson and Company Recent Developments
Table 75. GE Healthcare Company Details
Table 76. GE Healthcare Business Overview
Table 77. GE Healthcare Circulating Biomarker for Liquid Biopsy Product and Services
Table 78. GE Healthcare Circulating Biomarker for Liquid Biopsy Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 79. GE Healthcare Circulating Biomarker for Liquid Biopsy SWOT Analysis
Table 80. GE Healthcare Recent Developments
Table 81. Epigenomics AG Company Details
Table 82. Epigenomics AG Business Overview
Table 83. Epigenomics AG Circulating Biomarker for Liquid Biopsy Product and Services
Table 84. Epigenomics AG Circulating Biomarker for Liquid Biopsy Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 85. Epigenomics AG Circulating Biomarker for Liquid Biopsy SWOT Analysis
Table 86. Epigenomics AG Recent Developments
Table 87. Agilent Technologies Company Details
Table 88. Agilent Technologies Business Overview
Table 89. Agilent Technologies Circulating Biomarker for Liquid Biopsy Product and Services
Table 90. Agilent Technologies Circulating Biomarker for Liquid Biopsy Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 91. Agilent Technologies Circulating Biomarker for Liquid Biopsy SWOT Analysis
Table 92. Agilent Technologies Recent Developments
Table 93. Biocept Company Details
Table 94. Biocept Business Overview
Table 95. Biocept Circulating Biomarker for Liquid Biopsy Product and Services
Table 96. Biocept Circulating Biomarker for Liquid Biopsy Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 97. Biocept Circulating Biomarker for Liquid Biopsy SWOT Analysis
Table 98. Biocept Recent Developments
Table 99. Affymetrix Company Details
Table 100. Affymetrix Business Overview
Table 101. Affymetrix Circulating Biomarker for Liquid Biopsy Product and Services
Table 102. Affymetrix Circulating Biomarker for Liquid Biopsy Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 103. Affymetrix Circulating Biomarker for Liquid Biopsy SWOT Analysis
Table 104. Affymetrix Recent Developments
Table 105. Fluxion Biosciences Company Details
Table 106. Fluxion Biosciences Business Overview
Table 107. Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Product and Services
Table 108. Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 109. Fluxion Biosciences Circulating Biomarker for Liquid Biopsy SWOT Analysis
Table 110. Fluxion Biosciences Recent Developments
Table 111. Circulating Biomarker for Liquid Biopsy Market Trends
Table 112. Circulating Biomarker for Liquid Biopsy Market Drivers
Table 113. Circulating Biomarker for Liquid Biopsy Market Challenges
Table 114. Circulating Biomarker for Liquid Biopsy Market Restraints
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Circulating Biomarker for Liquid Biopsy Sales Market Share by Type: 2021 VS 2028
Figure 2. Circulating Tumor Cells (CTCs) Features
Figure 3. Circulating Tumor DNA (ctDNA) Features
Figure 4. Cell-Free DNA (cfDNA) Features
Figure 5. Extracellular Vesicles (EVs) Features
Figure 6. Others Features
Figure 7. Global Circulating Biomarker for Liquid Biopsy Sales Market Share by Application: 2021 VS 2028
Figure 8. Early Cancer Screening Case Studies
Figure 9. Therapy Selection Case Studies
Figure 10. Treatment Monitoring Case Studies
Figure 11. Recurrence Monitoring Orthopedics Case Studies
Figure 12. Circulating Biomarker for Liquid Biopsy Report Years Considered
Figure 13. Global Circulating Biomarker for Liquid Biopsy Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Circulating Biomarker for Liquid Biopsy Market Size 2017-2028 (US$ Million)
Figure 15. Global Circulating Biomarker for Liquid Biopsy Market Size Market Share by Region: 2021 VS 2028
Figure 16. Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Region in 2017 VS 2022
Figure 17. Global Top 10 Circulating Biomarker for Liquid Biopsy Countries Ranking by Market Size (US$ Million) in 2021
Figure 18. Global Circulating Biomarker for Liquid Biopsy Market Share by Players in 2021
Figure 19. Global Top Circulating Biomarker for Liquid Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Biomarker for Liquid Biopsy as of 2021)
Figure 20. The Top 10 and 5 Players Market Share by Circulating Biomarker for Liquid Biopsy Revenue in 2021
Figure 21. North America Circulating Biomarker for Liquid Biopsy Revenue Market Share by Company in 2021
Figure 22. North America Circulating Biomarker for Liquid Biopsy Revenue Market Share by Type (2017-2028)
Figure 23. North America Circulating Biomarker for Liquid Biopsy Revenue Market Share by Application (2017-2028)
Figure 24. North America Circulating Biomarker for Liquid Biopsy Revenue Share by Country (2017-2028)
Figure 25. U.S. Circulating Biomarker for Liquid Biopsy Revenue (2017-2028) & (US$ Million)
Figure 26. Canada Circulating Biomarker for Liquid Biopsy Revenue (2017-2028) & (US$ Million)
Figure 27. Europe Circulating Biomarker for Liquid Biopsy Revenue Market Share by Company in 2021
Figure 28. Europe Circulating Biomarker for Liquid Biopsy Revenue Market Share by Type (2017-2028)
Figure 29. Europe Circulating Biomarker for Liquid Biopsy Revenue Market Share by Application (2017-2028)
Figure 30. Europe Circulating Biomarker for Liquid Biopsy Revenue Share by Country (2017-2028)
Figure 31. Germany Circulating Biomarker for Liquid Biopsy Revenue (2017-2028) & (US$ Million)
Figure 32. France Circulating Biomarker for Liquid Biopsy Revenue (2017-2028) & (US$ Million)
Figure 33. U.K. Circulating Biomarker for Liquid Biopsy Revenue (2017-2028) & (US$ Million)
Figure 34. Italy Circulating Biomarker for Liquid Biopsy Revenue (2017-2028) & (US$ Million)
Figure 35. Russia Circulating Biomarker for Liquid Biopsy Revenue (2017-2028) & (US$ Million)
Figure 36. Asia Pacific Circulating Biomarker for Liquid Biopsy Revenue Market Share by Company in 2021
Figure 37. Asia Pacific Circulating Biomarker for Liquid Biopsy Revenue Market Share by Type (2017-2028)
Figure 38. Asia Pacific Circulating Biomarker for Liquid Biopsy Revenue Market Share by Application (2017-2028)
Figure 39. Asia Pacific Circulating Biomarker for Liquid Biopsy Revenue Share by Region (2017-2028)
Figure 40. China Circulating Biomarker for Liquid Biopsy Revenue (2017-2028) & (US$ Million)
Figure 41. Japan Circulating Biomarker for Liquid Biopsy Revenue (2017-2028) & (US$ Million)
Figure 42. South Korea Circulating Biomarker for Liquid Biopsy Revenue (2017-2028) & (US$ Million)
Figure 43. India Circulating Biomarker for Liquid Biopsy Revenue (2017-2028) & (US$ Million)
Figure 44. Australia Circulating Biomarker for Liquid Biopsy Revenue (2017-2028) & (US$ Million)
Figure 45. Taiwan Circulating Biomarker for Liquid Biopsy Revenue (2017-2028) & (US$ Million)
Figure 46. Indonesia Circulating Biomarker for Liquid Biopsy Revenue (2017-2028) & (US$ Million)
Figure 47. Thailand Circulating Biomarker for Liquid Biopsy Revenue (2017-2028) & (US$ Million)
Figure 48. Malaysia Circulating Biomarker for Liquid Biopsy Revenue (2017-2028) & (US$ Million)
Figure 49. Philippines Circulating Biomarker for Liquid Biopsy Revenue (2017-2028) & (US$ Million)
Figure 50. Vietnam Circulating Biomarker for Liquid Biopsy Revenue (2017-2028) & (US$ Million)
Figure 51. Latin America Circulating Biomarker for Liquid Biopsy Revenue Market Share by Company in 2021
Figure 52. Latin America Circulating Biomarker for Liquid Biopsy Revenue Market Share by Type (2017-2028)
Figure 53. Latin America Circulating Biomarker for Liquid Biopsy Revenue Market Share by Application (2017-2028)
Figure 54. Latin America Circulating Biomarker for Liquid Biopsy Revenue Share by Country (2017-2028)
Figure 55. Mexico Circulating Biomarker for Liquid Biopsy Revenue (2017-2028) & (US$ Million)
Figure 56. Brazil Circulating Biomarker for Liquid Biopsy Revenue (2017-2028) & (US$ Million)
Figure 57. Argentina Circulating Biomarker for Liquid Biopsy Revenue (2017-2028) & (US$ Million)
Figure 58. Middle East and Africa Circulating Biomarker for Liquid Biopsy Revenue Market Share by Company in 2021
Figure 59. Middle East and Africa Circulating Biomarker for Liquid Biopsy Revenue Market Share by Type (2017-2028)
Figure 60. Middle East and Africa Circulating Biomarker for Liquid Biopsy Revenue Market Share by Application (2017-2028)
Figure 61. Middle East and Africa Circulating Biomarker for Liquid Biopsy Revenue Share by Country (2017-2028)
Figure 62. Turkey Circulating Biomarker for Liquid Biopsy Revenue (2017-2028) & (US$ Million)
Figure 63. Saudi Arabia Circulating Biomarker for Liquid Biopsy Revenue (2017-2028) & (US$ Million)
Figure 64. UAE Circulating Biomarker for Liquid Biopsy Revenue (2017-2028) & (US$ Million)
Figure 65. Abbott Laboratories Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
Figure 66. Becton, Dickinson and Company Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
Figure 67. GE Healthcare Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
Figure 68. Epigenomics AG Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
Figure 69. Agilent Technologies Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
Figure 70. Biocept Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
Figure 71. Affymetrix Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
Figure 72. Fluxion Biosciences Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs